The MSRA exam is a mandatory part of the application for ophthalmology specialist training in the UK. It is a computer-based exam which is designed to assess junior doctors with foundation level competence. It is used for entry to postgraduate...
The FRCOphth Part 1 exam is a difficult exam with an average pass rate of 46% in the last year. It is a requirement before entry into the third year of ophthalmology specialty training (OST). Passing this exam during foundation...
Attempting the FRCOphth Part 1 examination as a foundation trainee requires significant time and financial commitment. Unlike the MRCP and MRCS examinations, the curriculum of this exam does not overlap with the undergraduate syllabus. As such, it is a steep...
As a trainee in ophthalmology, every day you are learning more and more about the specialty. In addition, you will most likely be exploring the vast array of subspecialties that ophthalmology has to offer, and would probably be trying to...
The Duke Elder undergraduate prize examination is an annual exam organised by the Royal College of Ophthalmologists in the United Kingdom. Named after Sir Stewart Duke Elder, a prominent British ophthalmologist, the exam is designed to encourage undergraduate medical students...
5 September 2023
| Zainab Mehmood, Qasim Mansoor
|
EYE - General
Importance of work experience Medical schools expect applicants to understand what a career in medicine involves, which can be gained through work experience and volunteering. It is strongly recommended by the Medical Schools Council that work experience involves working in...
14 June 2023
| Aina Pons, Abhinav Loomba, Siddharth Goel
|
EYE - Cornea
Recurrent corneal erosion syndrome is a common, recurrent condition caused by abnormal epithelial adhesion to the underlying basal lamina. Spontaneous breakdown of the corneal epithelium can lead to the sudden onset of ocular pain, blurred vision, tearing and photophobia, typically...
Revolutionary eye treatments offer hope for children facing blindness from CLN2 batten disease. Robert Henderson discusses this, and his use of Heidelberg Engineering’s Spectralis device to better combat it. Pioneering research from Great Ormond Street Hospital (GOSH) and the University...
Gene and cell therapies offer the prospect of ground-breaking new avenues for the treatment of diseases, reflected in a renewed explosion of interest and investment in retinal gene therapy. Rod McNeil reports recent clinical trial readouts across a diverse range...
Diabetic macular oedema (DMO) is a common complication associated with diabetic retinopathy, and the most common cause of visual impairment in diabetes [1]. With predicted rising levels of diabetes (in England by 2025 the estimated population with diabetes will be...
1 February 2016
| Fiona Harris, Spyridon Chalkiadakis, Simon Taylor (Prof)
|
EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a major cause of visual loss in diabetes, with a complex multifactorial pathogenesis. In the UK alone it is estimated that there are nearly 2.5 million diabetic patients aged over 12 years. Approximately 65,000 of...
3 April 2023
| Mattan Arazi, Oteri Okolo, Dupe Ademola-Popoola, Richard Bowman, Ido Didi Fabian, Covadonga Bascaran, Marcia Zondervan
|
EYE - General
This is the first in a series of three articles (see Part 2 here) about strengthening eye health services in Nigeria through collaboration with the LINKS and Networks run at the International Centre for Eye Health, London School of Hygiene...